Carestream prepares to unveil RIS/PACS pricing

Carestream prepares to unveil RIS/PACS pricingOther headlines:IDC revenues plummetMindray revenues skyrocketAmicas slips in 1Q

Carestream prepares to unveil RIS/PACS pricing

Carestream will focus on a new licensing structure for its latest generation of RIS/PACS at the Society for Imaging Informatics in Medicine meeting June 4 to 7. The new licensing approach offers tiered pricing tied to imaging volume. This approach allows for enterprise-wide use of the suite's advanced features for users of all sizes, according to the company. Key features of the Carestream PACS are a new PowerViewer workstation, new RIS for centralized enterprise-wide scheduling, and new "SuperPACS" architecture that creates a single user interface for disparate PACS.

IDC revenues plummet

A slowing economy cut gross revenues 58.8% at Imaging Dynamics Company for the quarter ended March 31 compared with the year-earlier period, but the digital radiography firm trimmed its losses by 40%. The company credited a reduced cash burn and better capital managing for the improved bottom line. Net loss for the quarter was $1.5 million compared with $2.5 million in the same quarter 2008. Net revenues were $2.6 million versus $6.4 million in 1Q 08.

Mindray revenues skyrocket

Net revenues boomed 53.5% for Mindray Medical International in the first quarter over the year-earlier period, but profits edged barely higher. Net income grew 1.2% to $25.3 million for the Chinese medical device maker, whose portfolio includes ultrasound scanners. Quarterly revenues rose to $134.2 million from $87.4 million. Ultrasound revenues increased 32.9% to $35.7 million, contributing 26.6% to the total net revenues in the first quarter 2009.

Amicas slips in 1Q

Revenues dropped 12% in the first quarter at Amicas, ballooning the PACS/IT company's operating losses 33% (to $1.6 million) compared with the year-earlier period. Total revenues in the quarter ended March 31 were $11.3 million compared with $12.8 million in 1Q 08. The $1.6 million operating loss included $549,000 in expenses related to the acquisition and integration of Emageon.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.